This also suggests that TP53 mutation status may play a critical role in cellular processes previously shown to involve NOX4, such as EMT, cell migration, angiogenesis and other genetic and metabolic programs that promote cancer progression [15,16,20,37,38]. The gene discussed is NOX4; the disease is cancer.